Genomic Diversity of SARS-CoV-2 Omicron Sublineages and Co-Circulation with Respiratory Viruses in Pediatric Patients in Sao Paulo, Brazil
The SARS-CoV-2 Omicron variant caused a global surge in COVID-19 cases following its emergence in November 2021, rapidly diversifying in the subsequent months. Although many studies have documented Omicron's diversification, few have explored its impact on pediatric populations or the seasonality of other respiratory viruses in children. This study aims to investigate the diversity and circulation patterns of SARS-CoV-2 Omicron sublineages in pediatric patients in São Paulo, Brazil, and assess their co-circulation with other respiratory pathogens. Respiratory samples collected from patients under 18 years old across five hospitals between January 2022 and April 2023 were tested for different respiratory viruses using real-time RT-PCR. Whole-genome sequencing was performed on SARS-CoV-2-positive samples. Among the 7868 pediatric respiratory samples tested, 3902 were positive for viral pathogens. Respiratory Syncytial Virus accounted for the highest number of positive cases (<i>n</i> = 1248), exhibiting an atypical off-season peak in November 2022. SARS-CoV-2 was detected in 297 samples, of which 103 were sequenced. BA.1 and BA.5 sublineages had predominant genomic diversity and circulation time. These findings highlight the Omicron variant's significant impact on the epidemiology and seasonal distribution of respiratory viruses in children, emphasizing the ongoing need for vaccination and robust surveillance efforts in pediatric populations.
Authors
- Vanessa Nascimento Chalup (ORCID: https://orcid.org/0000-0002-9433-0443)
- João Renato Rebello Pinho (ORCID: https://orcid.org/0000-0003-3999-0489)
- Vera Bain (ORCID: https://orcid.org/0000-0002-5290-6897)
- Jansen de Araújo (ORCID: https://orcid.org/0000-0002-7250-3024)
- Edison Luíz Durigon (ORCID: https://orcid.org/0000-0003-4898-6553)
- Guilherme Pereira Scagion (ORCID: https://orcid.org/0000-0003-0160-9515)
- Carolina Sucupira (ORCID: https://orcid.org/0000-0003-4163-8126)
- Cairo Oliveira Monteiro (ORCID: https://orcid.org/0000-0003-3792-1965)
- Marco Aurélio Palazzi Sáfadi (ORCID: https://orcid.org/0000-0002-4401-9446)
- Danielle Bruna Leal Oliveira (ORCID: https://orcid.org/0000-0002-0534-0886)
- Marcelo Otsuka (ORCID: https://orcid.org/0000-0001-5474-9883)
- Camila Araújo Valério (ORCID: https://orcid.org/0000-0001-5982-7983)
- Bruna Larotonda Telezynski (ORCID: https://orcid.org/0000-0002-8179-9015)
- Camila de Morais Rodrigues (ORCID: https://orcid.org/0000-0001-8858-3885)
- Mariana Pereira Soledade
- Luciana Becker Mau (ORCID: https://orcid.org/0000-0001-7626-6401)
- Luciano M. Thomazelli (ORCID: https://orcid.org/0000-0002-9157-6122)
- Giovana Santos Caleiro
- Flávia Jacqueline Almeida (ORCID: https://orcid.org/0000-0002-8587-9733)
- Erick Gustavo Dorlass (ORCID: https://orcid.org/0000-0001-8169-3133)
- Ana Karolina Antunes Eisen (ORCID: https://orcid.org/0000-0003-0144-1695)
- Andressa Aguiar (ORCID: https://orcid.org/0000-0003-1779-5033)
- Isabela Barbosa de Assis (ORCID: https://orcid.org/0000-0002-1776-5216)
- Fabyano Bruno Leal de Oliveira
Institutions
- Universidade de São Paulo (BR)
- Hospital Israelita Albert Einstein (BR)
- Hospital do Servidor Público Municipal (BR)
- Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR)
- Hospital Materno-Infantil (ES)
- Hospital Infantil Albert Sabin (BR)
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR)
- Hospital São Paulo (BR)
Publication Details
- Journal
- Viruses
- Published
- 2025-10-25
- DOI
- https://doi.org/10.3390/v17111421
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00